|
|
|
|
| Чувство |
|
|
|
| насыщения и склонность к перееданию |
|
|
|
|
|
|
|
| FTO |
|
|
|
|
|
|
|
| rs9939609 |
|
|
|
|
|
|
|
|
|
|
|
| MC4R |
|
|
|
|
|
|
|
| rs17782313 |
|
|
|
|
|
|
|
| Особенности метаболизма |
|
|
|
|
|
|
|
| Тип |
|
|
|
| базового энергообмена |
|
|
|
|
|
|
|
| PPARG2 |
|
|
|
|
|
|
|
| rs1801282 |
|
|
|
|
|
|
|
|
|
|
|
| ADRB3 |
|
|
|
|
|
|
|
| rs4994 |
|
|
|
|
|
|
|
|
|
|
|
| ADRB2 |
|
|
|
|
|
|
|
| rs1042713 |
|
|
|
|
|
|
|
|
|
|
|
| ADRB2 |
|
|
|
|
|
|
|
| rs1042714 |
|
|
|
|
|
|
|
|
|
|
|
| FABP2 |
|
|
|
|
|
|
|
| rs1799883 |
|
|
|
|
|
|
|
| Уровень общего холестерина |
|
|
|
| APOE |
|
|
|
|
|
|
|
| rs429358 |
|
|
|
|
|
|
|
|
|
|
|
| APOE |
|
|
|
|
|
|
|
| rs7412 |
|
|
|
|
|
|
|
|
|
|
|
| APOC1 |
|
|
|
|
|
|
|
| rs4420638 |
|
|
|
|
|
|
|
| Повышение уровня ЛПНП |
|
|
|
| APOE |
|
|
|
|
|
|
|
| rs429358 |
|
|
|
|
|
|
|
|
|
|
|
| APOE |
|
|
|
|
|
|
|
| rs7412 |
|
|
|
|
|
|
|
|
|
|
|
| APOC1 |
|
|
|
|
|
|
|
| rs4420638 |
|
|
|
|
|
|
|
|
|
|
|
| ABCG8 |
|
|
|
|
|
|
|
| rs6544713 |
|
|
|
|
|
|
|
| Снижение уровня ЛПВП |
|
|
|
| ABCA1 |
|
|
|
|
|
|
|
| rs2230806 |
|
|
|
|
|
|
|
|
|
|
|
| APOA1 |
|
|
|
|
|
|
|
| rs670 |
|
|
|
|
|
|
|
|
|
|
|
| LPL |
|
|
|
|
|
|
|
| rs268 |
|
|
|
|
|
|
|
| Повышение уровня триглицеридов |
|
|
|
| APOA5 |
|
|
|
|
|
|
|
| rs3135506 |
|
|
|
|
|
|
|
|
|
|
|
| Intergenic |
|
|
|
|
|
|
|
| rs12272004 |
|
|
|
|
|
|
|
|
|
|
|
| LPL |
|
|
|
|
|
|
|
| rs268 |
|
|
|
|
|
|
|
|
|
|
|
| FADS1 |
|
|
|
|
|
|
|
| rs174547 |
|
|
|
|
|
|
|
|
|
|
|
| GCKR |
|
|
|
|
|
|
|
| rs1260326 |
|
|
|
|
|
|
|
|
|
|
|
| APOE |
|
|
|
|
|
|
|
| rs429358 |
|
|
|
|
|
|
|
|
|
|
|
| APOE |
|
|
|
|
|
|
|
| rs7412 |
|
|
|
|
|
|
|
| Углеводный обмен |
|
|
|
| SLC30A8 |
|
|
|
|
|
|
|
| rs13266634 |
|
|
|
|
|
|
|
|
|
|
|
| TCF7L2 |
|
|
|
|
|
|
|
| rs7903146 |
|
|
|
|
|
|
|
|
|
|
|
| TCF7L2 |
|
|
|
|
|
|
|
| rs12255372 |
|
|
|
|
|
|
|
|
|
|
|
| KCNJ11 |
|
|
|
|
|
|
|
| rs5219 |
|
|
|
|
|
|
|
|
|
|
|
| PPARG2 |
|
|
|
|
|
|
|
| rs1801282 |
|
|
|
|
|
|
|
|
|
|
|
| ADRB2 |
|
|
|
|
|
|
|
| rs1042713 |
|
|
|
|
|
|
|
|
|
|
|
| ADRB2 |
|
|
|
|
|
|
|
| rs1042714 |
|
|
|
|
|
|
|
| Метаболизм витаминов |
|
|
|
| Витамин А |
|
|
|
| BCMO1 |
|
|
|
|
|
|
|
| rs12934922 |
|
|
|
|
|
|
|
|
|
|
|
| BCMO1 |
|
|
|
|
|
|
|
| rs7501331 |
|
|
|
|
|
|
|
| Витамин D |
|
|
|
| GC |
|
|
|
|
|
|
|
| rs2282679 |
|
|
|
|
|
|
|
|
|
|
|
| VDR |
|
|
|
|
|
|
|
| rs1544410 |
|
|
|
|
|
|
|
|
|
|
|
| DHCR7 |
|
|
|
|
|
|
|
| rs12785878 |
|
|
|
|
|
|
|
|
|
|
|
| CYP2R1 |
|
|
|
|
|
|
|
| rs10741657 |
|
|
|
|
|
|
|
| Витамин B6 |
|
|
|
| ALPL |
|
|
|
|
|
|
|
| rs1256335 |
|
|
|
|
|
|
|
|
|
|
|
| NBPF3 |
|
|
|
|
|
|
|
| rs4654748 |
|
|
|
|
|
|
|
| Фолиевая кислота (витамин B9) |
|
|
|
| MTHFR |
|
|
|
|
|
|
|
| rs1801133 |
|
|
|
|
|
|
|
|
|
|
|
| MTHFR |
|
|
|
|
|
|
|
| rs1801131 |
|
|
|
|
|
|
|
| Витамин B12 |
|
|
|
| FUT2 |
|
|
|
|
|
|
|
| rs602662 |
|
|
|
|
|
|
|
| Витамин С |
|
|
|
| SLC23A1 |
|
|
|
|
|
|
|
| rs33972313 |
|
|
|
|
|
|
|
| Витамин Е |
|
|
|
| APOA5 |
|
|
|
|
|
|
|
| rs3135506 |
|
|
|
|
|
|
|
|
|
|
|
| Intergenic |
|
|
|
|
|
|
|
| rs12272004 |
|
|
|
|
|
|
|
| Омега 3, 6 жирные кислоты |
|
|
|
| FADS1 |
|
|
|
|
|
|
|
| rs174547 |
|
|
|
|
|
|
|
| Реакция на пищевые продукты |
|
|
|
| Непереносимость алкоголя |
|
|
|
| ADH1B |
|
|
|
|
|
|
|
| rs1229984 |
|
|
|
|
|
|
|
|
|
|
|
| ALDH2 |
|
|
|
|
|
|
|
| rs671 |
|
|
|
|
|
|
|
| Непереносимость лактозы |
|
|
|
| LCT |
|
|
|
|
|
|
|
| rs4988235 |
|
|
|
|
|
|
|
| Непереносимость глютена |
|
|
|
| HLA-DQ2.5 |
|
|
|
|
|
|
|
| rs2187668 |
|
|
|
|
|
|
|
|
|
|
|
| HLA-DQ8 |
|
|
|
|
|
|
|
| rs7454108 |
|
|
|
|
|
|
|
| Метаболизм кофеина |
|
|
|
| CYP1A2 |
|
|
|
|
|
|
|
| rs762551 |
|
|
|
|
|
|
|
| Необходимость ограничивать пищевую соль |
|
|
|
| ADD1 |
|
|
|
|
|
|
|
| rs4961 |
|
|
|
|
|
|
|
|
|
|
|
| CYP11B2 |
|
|
|
|
|
|
|
| rs1799998 |
|
|
|
|
|
|
|
|
|
|
|
| AGT |
|
|
|
|
|
|
|
| rs699 |
|
|
|
|
|
|
|
|
|
|
|
| ACE |
|
|
|
|
|
|
|
| rs4340 |
|
|
|
|
|
|
|
| Физическая нагрузка и спортивная активность |
|
|
|
| Интенсивность физической нагрузки |
|
|
|
| ADRB3 |
|
|
|
|
|
|
|
| rs4994 |
|
|
|
|
|
|
|
|
|
|
|
| ADRB2 |
|
|
|
|
|
|
|
| rs1042713 |
|
|
|
|
|
|
|
| Мышечная сила |
|
|
|
| PPARA |
|
|
|
|
|
|
|
| rs4253778 |
|
|
|
|
|
|
|
|
|
|
|
| PPARG2 |
|
|
|
|
|
|
|
| rs1801282 |
|
|
|
|
|
|
|
|
|
|
|
| PGC1A |
|
|
|
|
|
|
|
| rs8192678 |
|
|
|
|
|
|
|
|
|
|
|
| ACE |
|
|
|
|
|
|
|
| rs4340 |
|
|
|
|
|
|
|
| Склонность к повышению давления после физической нагрузки |
|
|
|
| ACE |
|
|
|
|
|
|
|
| rs4340 |
|
|
|
|
|
|
|
|
|
|
|
| AGT |
|
|
|
|
|
|
|
| rs699 |
|
|
|
|
|
|
|
| Скорость восстановления после физической нагрузки |
|
|
|
| AMPD1 |
|
|
|
|
|
|
|
| rs17602729 |
|
|
|
|
|
|
|
|
|
|
|
| IL6 |
|
|
|
|
|
|
|
| rs1800795 |
|
|
|
|
|
|
|